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Background: Very little is known about the link of T. gondii infection and depression. Through an age-, gender-,
and month of pregnancy-matched case-control study, we determined the association of T. gondii infection and
depression in pregnant women.
Methods: We studied 200 pregnant women with depression and 200 pregnant women without depression
attended in a public hospital in Durango City, Mexico. Pregnant women were tested for the presence of anti-
Toxoplasma IgG antibodies using an enzyme-linked immunoassay (EIA), and IgG seropositive women were further
tested for the presence of IgM using an EIA. IgM positivity by EIA was further analyzed by enzyme-linked
fluorescence assay (ELFA).
Results: Anti-T. gondii IgG antibodies were found in 9 (4.5%) of the 200 cases and in 12 (6.0%) of the 200 controls
(OR = 0.73; 95% CI: 0.30–1.79; P = 0.50). The frequency of high (>150 IU/ml) anti-T. gondii IgG levels was similar in
cases and in controls (OR = 1.20; 95% CI: 0.36–4.01; P = 0.75). Two women were positive for IgM by EIA but both
were negative by ELFA.
Conclusions: We did not find serological evidence of an association between T. gondii infection and depression in
pregnant women attended in a public hospital in Durango City, Mexico. Since an association of T. gondii and
depression in pregnancy has been reported in the U.S. previously, further research to elucidate the role of T. gondii
in prenatal depression should be conducted.
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Toxoplasma gondii (T. gondii) is a widely-distributed
parasite [1], transmitted to humans by ingestion of raw or
undercooked meat containing tissue cysts, and ingestion
of food or water contaminated with oocysts shed by cats
[2, 3]. Primary infections in pregnant women may result
in vertical transmission leading to congenital infections
and disease [4, 5]. Although most infections with T. gondii
are asymptomatic, some infected individuals develop a* Correspondence: alvaradocosme@yahoo.com
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lymph nodes and central nervous system [6, 7]. Immuno-
compromised individuals infected with T. gondii are at risk
for a reactivation of the infection leading to a severe dis-
ease mainly of the central nervous system [8]. Infection
with T. gondii has been linked to psychiatric disorders in-
cluding schizophrenia [9, 10], bipolar disorder, obsessive-
compulsive disorder, and addiction [9]. However, the link
between T. gondii infection and depression is controver-
sial. In a Cuban study of psychiatric patients, those suffer-
ing from depressive disorders had the highest frequency of
reactivity to the toxoplasmin intradermal test [11]. How-
ever, in a population-representative birth-cohort of indi-
viduals in Dunedin, New Zealand, T. gondii seropositivityle is distributed under the terms of the Creative Commons Attribution 4.0
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[12]. Similarly, in a meta-analysis of 50 studies into T. gon-
dii infection for major psychiatric disorders versus healthy
controls, no association between T. gondii IgG seropreva-
lence and major depression was found [9]. The association
of T. gondii infection and depression in pregnant women
has been poorly studied. Groër et al. found that higher
anti-T. gondii IgG titers in infected women in the USA
were related to depression and anxiety during pregnancy
[13]. We aimed to determine whether T. gondii infection
is associated with depression in pregnant women attended
in a public hospital in Durango City, Mexico.
Methods
Study design and population studied
We performed an age-, gender-, and month of pregnancy-
matched case-control study of 200 pregnant women suf-
fering from depression and 200 pregnant women without
depression attended in a public hospital in Durango City,
Mexico. This study was performed from March 2015 to
February 2016. Inclusion criteria for enrollment of partici-
pants were: 1) pregnant women suffering from depression
attending prenatal care consultations in the General Hos-
pital of the Secretary of Health in Durango City; 2) aged
13 years and older; and 3) who accepted to participate in
the study. Socioeconomic status was not a restrictive cri-
terion for enrollment. Mean age in cases was 23.40 ± 8.36
(range 13–43) years old. Depressed pregnant women had
2–8 months of pregnancy (mean 6.5 ± 1.5 months). As a
strategy to screen depression in pregnant women,
validated Mexican versions of the Edinburgh postnatal de-
pression scales (EPDS) (Additional file 1) were used in
adults [14] and teenagers [15]. Pregnant women who
screened positive for depression in the EPDS were further
examined by a psychiatrist to confirm depression using
the Diagnostic and Statistical Manual of Mental Disorders,
Fifth edition criteria [http://www.dsm5.org/Pages/Defaul
t.aspx]. Control pregnant women were matched with cases
for age. Controls were randomly selected, and they scored
negative for depression in the EPDS. Inclusion criteria for
enrollment of control pregnant women were: 1) pregnant
women without depression attending prenatal consulta-
tions in the General Hospital of the Secretary of Health in
Durango City; 2) aged 13 years and older; and 3) who ac-
cepted to participate in the study. Mean age in control
women was 23.01 ± 7.55 (range 13–45) years old. Preg-
nant women without depression had 2–9 months of preg-
nancy (mean 6.7 ± 1.5 months). No statistically significant
differences in age (P = 0.62), and month of pregnancy be-
tween cases and controls were found.
Detection of anti-T. gondii antibodies
Serum samples from participants were obtained and
stored at −20 °C until analyzed. The presence of anti-T.gondii IgG antibodies was tested in sera using the com-
mercially available enzyme immunoassay (EIA) kit
“Toxoplasma IgG” (Diagnostic Automation/Cortez Diag-
nostics Inc., Woodland Hills, CA, USA). Anti-T. gondii
IgG antibody levels were expressed as International
Units (IU)/ml, and a cut-off for seropositivity of 8 IU/ml
was used. Sera positive for anti-T. gondii IgG antibodies
were further tested for anti-T. gondii IgM antibodies by
using the commercially available EIA “Toxoplasma IgM”
kit (Diagnostic Automation/Cortez Diagnostics Inc.). In
addition, sera positive for anti- T. gondii IgM antibodies
by EIA were further analyzed for these anti-T. gondii IgM
antibodies using the commercially available enzyme-
linked fluorescent assay (ELFA) kit “VIDAS Toxo IgM”
(BioMérieux, Marcy-l’Etoile, France). All IgG and IgM
assays were performed following the instructions of the
manufacturers.
Statistical analysis
Analysis was conducted using the software Epi Info 7
and SPSS 15.0 (SPSS Inc. Chicago, Illinois). For calcula-
tion of the sample size, we used a 95% confidence level,
a power of 80%, a 1:1 proportion of cases and controls, a
reference seroprevalence of 6.1% [16] as the expected
frequency of exposure in controls, and an odds ratio of
2.8. The result of the sample size calculation was 195
cases and 195 controls. We used the student’s t test to
compare the age among cases and controls. The associ-
ation of T. gondii infection and depression in pregnant
women was assessed with the two-tailed Pearson’s chi-
squared test. Odds ratio (OR) and 95% confidence inter-
val (CI) were calculated, and a P value < 0.05 was consid-
ered statistically significant.
Results
Of the 200 cases of depression included in the study,
122 (61.0%) suffered from minor depression, and 78
(39.0%) from major depression. Anti-T. gondii IgG anti-
bodies were found in 9 (4.5%) of the 200 cases and in 12
(6.0%) of the 200 controls. The seroprevalence of T. gon-
dii infection was similar in cases and in controls (OR =
0.73; 95% CI: 0.30–1.79; P = 0.50). Of the 9 anti-T. gondii
IgG positive cases, 6 (66.7%) had IgG levels higher than
150 IU/ml, one (11.1%) between 100 and 150 IU/ml, and
2 (22.2%) between 8 and 99 IU/ml. In contrast, of the 12
anti-T. gondii IgG positive controls, 5 (41.7%) had IgG
levels higher than 150 IU/ml, one (8.3%) between 100
and 150 IU/ml, and 6 (50.0%) between 8 and 99 IU/ml.
The frequency of high (>150 IU/ml) anti-T. gondii IgG
levels was similar in cases and in controls (OR = 1.20;
95% CI: 0.36–4.01; P = 0.75). Seroprevalence of T. gondii
infection in patients with minor depression (4/122: 3.3%)
was comparable to that (5/78: 6.4%) found in patients
with major depression (P = 0.29). Stratification by age
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show differences (P > 0.05) in seroprevalences among
cases and controls (3/149: 2.0% versus 10/159: 6.3%, and
6/51: 11.8% versus 2/41: 4.9%, respectively). Stratification
by month of pregnancy groups (2–5 months, and more
than 5 months) did not show differences (P > 0.05) in
seroprevalences (2% versus 8.7%, and 5.4% versus 5.2%,
respectively) or high IgG antibody levels (2% versus
4.3%, and 3.4% versus 1.9%, respectively) among cases
and controls. None of the 9 anti-T. gondii IgG seroposi-
tive cases was reactive to anti-T. gondii IgM antibodies
by EIA. Whereas 2 of the 12 anti-T. gondii IgG seroposi-
tive controls were reactive to IgM by EIA. These 2 IgM
positive sera by EIA were negative to IgM by ELFA.
Thus, none of the cases and controls was considered
seropositive to IgM.
Discussion
Studies about the association of T. gondii infection and
depression have shown conflicting results [9, 11, 12]. In
addition, the association of T. gondii infection and pre-
natal depression has been poorly studied in particular.
Therefore, the present study aimed to determine whether
T. gondii infection is associated with depression in a sam-
ple of pregnant women in Durango City, Mexico. Results
of tests for detection of T. gondii performed in the present
study included qualitative and quantitative IgG and IgM
assays. Our results do not point towards an increased rate
of depression in pregnant women infected with T. gondii
compared to matched control patients attended in the
same hospital. We are aware of only one study on the link
of T. gondii infection and depression in pregnancy. In
such study, 414 women at 16–25 weeks of gestation in the
USA were examined, and researchers found that higher T.
gondii IgG antibody titers were associated with prenatal
depression [13]. Authors hypothesized that immune es-
cape of T. gondii may occur due to immune changes in
pregnancy, and this could cause depression through acti-
vation of indoleamine 2, 3-dehydroxylase resulting in
serotonin decrease [13]. It is not clear why the association
of infection and depression was found in pregnant women
in the USA but not in pregnant women in the current
study. Comparison of both studies was based on IgG sero-
positivity; however, IgM seropositivity was not compared
because this marker for acute or recent infection was not
determined in the American study. It is possible that dif-
ferences in the characteristics of pregnant women among
the studies may explain the differences in the association.
In the U.S. study, researchers examined women at 16–25
weeks of pregnancy whereas we examined women at 2–9
months of pregnancy. Stratification by month of
pregnancy groups (2–5 months, and >5 months) did not
show an association of infection and prenatal depression
in the current study. While our study did not find anyassociation of infection with T. gondii and depression in
pregnant women several studies have demonstrated a link
between T. gondii infection and depression. T. gondii sero-
positivity correlated with the Center for Epidemiologic
Studies Depression score, Profile for Mood States-
depression, and total mood disturbance score in a study of
women veterans in the USA [17]. The age of women in
the latter study was higher than in our study. Experimen-
tal evidence exists that reactivation of chronic T. gondii in-
fection in mice by an immunosuppressive regimen caused
depression-like behaviors, specifically, reduced sucrose
preference, and increased immobility in the forced-swim
test [18]. Researchers of the latter study also observed an
enhanced tryptophan catabolic shunt and serotonin turn-
over that may be involved in the development of the
depressive-like behaviors [18]. Reactivation of latent infec-
tion in humans is often observed in immunocompromised
patients leading to life-threatening toxoplasmic encephal-
itis; it is therefore difficult to study an association with
depression.
False positive results have been reported in anti-T.
gondii IgM antibody tests [19]. Therefore, to increase
the specificity of IgM seropositivity, we used two
methods to test for anti-T. gondii IgM antibodies (EIA
and ELFA). No acute cases of T. gondii infection were
found, and therefore, treatment against T. gondii in the
pregnant women studied was not needed.
Our study has limitations. First, we investigated the asso-
ciation of infection with T. gondii and depression in a rela-
tively small cohort of pregnant women attending a public
hospital. Therefore, our results cannot be extrapolated to
pregnant women with different social status, i.e., those
attended in private hospitals or other public hospitals. The
great majority of women attended in the participating hos-
pital had a low socioeconomic status.Conclusions
We did not observe serological evidence of an associ-
ation between T. gondii infection and depression in
pregnant women attended in a public hospital in Du-
rango City, Mexico. Our results conflict with those re-
ported in a previous study in the USA therefore
warranting further research to elucidate the role of T.
gondii in prenatal depression.Additional file
Additional file 1: Tool used to screen depression. (DOCX 15 kb)
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